1. Home
  2. ARL vs CGEN Comparison

ARL vs CGEN Comparison

Compare ARL & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Realty Investors Inc.

ARL

American Realty Investors Inc.

HOLD

Current Price

$14.50

Market Cap

233.9M

Sector

Real Estate

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$3.11

Market Cap

188.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARL
CGEN
Founded
1999
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.9M
188.2M
IPO Year
1999
2001

Fundamental Metrics

Financial Performance
Metric
ARL
CGEN
Price
$14.50
$3.11
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
1.9K
398.6K
Earning Date
05-08-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
206.59
N/A
EPS
0.97
N/A
Revenue
$50,014,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$75.09
P/E Ratio
$15.02
N/A
Revenue Growth
5.70
N/A
52 Week Low
$11.29
$1.23
52 Week High
$20.00
$2.99

Technical Indicators

Market Signals
Indicator
ARL
CGEN
Relative Strength Index (RSI) 44.63 79.18
Support Level $13.66 $1.45
Resistance Level $15.95 N/A
Average True Range (ATR) 0.45 0.18
MACD 0.06 0.03
Stochastic Oscillator 51.24 88.57

Price Performance

Historical Comparison
ARL
CGEN

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments: the acquisition, development, ownership and management of multifamily properties (Residential Segment) and the acquisition, ownership and management of commercial real estate properties (Commercial Segment). Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: